Funding for this research was provided by:
Capital Region of Denmark, Foundation for Health Research (-)
Text and Data Mining valid from 2019-11-12
Received: 11 July 2019
Accepted: 3 October 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: Registry-based studies do not require ethical approval in Denmark, and data were anonymized with no possibility for identification of individual patients. The study was approved by the Danish Data Protection Agency (ref. 2007–58-015 / I-suite no. 02736 GEH-2014-018).
: Not applicable.
: EKL, ANB, LS, A-LK, and NC have nothing to declare. GG: Research grants from Pfizer, Bristol-Myers Squibb, Bayer and Boehringer Ingelheim. JBO: Speaker for Bristol-Myers Squibb, Boehringer Ingelheim, Bayer, and AstraZeneca. Consultant for Bristol-Myers Squibb, Boehringer Ingelheim, Novartis Healtcare, and Novo Nordisk. Funding for research from Bristol-Myers Squibb and The Capital Region of Denmark, Foundation for Health Research. CT-P: research support from Bayer.